Embolization Coils Market is Predicted to Reach US$ 1,591.61 million by 2028 Says, The Insight Partners

The embolization coils market was valued US$ 1,191.78 million in 2021. It is estimated to grow at a CAGR of 4.3% during 2022–2028.

NEW YORK, UNITED STATES, January 9, 2023 /EINPresswire.com/ -- According to The Insight Partners latest study, titled “Embolization Coils Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Material, Application, End User, and Geography," the market is expected to reach US$ 1,591.60 million by 2028 from US$ 1,191.78 million in 2021. It is estimated to grow at a CAGR of 4.3% during 2022–2028. The report highlights the key factors driving the global embolization coils market and prominent players with their developments in the embolization coils market.

The growth of the global embolization coils market is primarily attributed to the rise in prevalence of cardiac aneurysms, increase in the incidence of cancer cases, rise in patient preference for minimally invasive procedures, and surge in the incidence of hypertension, obesity, smoking, and alcoholism. However, the high cost of embolization coils and numerous product recalls are expected to restrict the market growth during the forecast period.

Download Sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPHE100001434/

Terumo Corporation; Medtronic plc; Boston Scientific Corporation; Stryker Corporation; Johnson & Johnson; Cook Medical; Penumbra, Inc.; Kaneka Corporation; Shape Memory Medical INC.; and Microport Scientific Corporation are among the key players operating in the global embolization coils market. In December 2019, Kaneka Corporation developed a new coil for embolization of brain aneurysms (product name: i-ED Coil), and from November, it began sales in Japan. It is currently under review by the US Food and Drug Administration (FDA), and once approved, it is scheduled to begin selling in the US. Kaneka is aiming for global sales of JPY 10 billion by 2023.

Based on type, the global embolization coils market is bifurcated into detachable coil and pushable coil. In terms of material, the market is segmented into platinum, platinum & hydrogel, and platinum tungsten alloy. Based on application, the global embolization coils market is segmented into neurology, cardiology, urology, oncology, peripheral vascular disease, and others. Based on end user, the global embolization coils market is segmented into hospital, cardiac center, ambulatory centers, and other. Based on geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America)

Embolization coils are generally used to treat brain aneurysms and arteriovenous malformations (AVMs) in the field of neurology. An AVM is a tangle of blood vessels connecting arteries and veins that causes disruption in blood flow and oxygen circulation, resulting in the lack of oxygen for surrounding tissues. The abnormally tangled blood vessels that make up the AVM can also weaken and rupture. If an AVM ruptures in the brain, it can result in brain bleeding (hemorrhage), stroke, or brain damage. The cerebral aneurysm is also known as intracranial aneurysm or brain aneurysm. This is a bulging, weakened area on the wall of an artery in the brain, which further results in an abnormal widening like a balloon or a bleb shape. Embolization of brain aneurysms and AVM uses imaging-guided techniques to place small and soft metal coils into an aneurysm to block blood flow and prevent the aneurysm's rupture. Various embolization agents such as coils and liquid embolic agents are used in embolization procedures.

Below is the list of the growth strategies done by the players operating in the Embolization Coils market:

Year News
Jan-2019 Terumo Announces Novel Intrasaccular Aneurysm Treatment Device Receives FDA PMA Approval
May-2022 FDA clears new solutions from Boston Scientific, CathVision, Franklin Mountain Medical
Dec-2019 Kaneka releases a new coil for embolization of brain aneurysms
May-2022 MicroPort NeuroTech Completes First Implantation of Numen Coil Embolization System in the U.S.
May-2019 Shape Memory Medical gets FDA nod for Impede-FX embolization plug
Jun-2022 Kaneka releases a new coil for embolization of brain aneurysms
Aug-2022 Boston Scientific Corporation BSX announced the acquisition of Obsidio, Inc. It is a privately held company is the renowned developer of the FDA-authorized Gel Embolic Material (GEM) technology.

Ask for Discount at: https://www.theinsightpartners.com/discount/TIPHE100001434/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.
We understand syndicated reports may not meet precise research requirements of all our clients. We offer our clients multiple ways to customize research as per their specific needs and budget.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

Sameer Joshi
The Insight Partners
+ +91 96661 11581
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn